A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19Meta-Analysis Published on 2020-11-012023-07-12 Journal: International Journal of Infectious Diseases [Category] SARS, [키워드] Antithrombotic Coagulation COVID-19 heparin [DOI] 10.1016/j.ijid.2020.08.023 PMC 바로가기 [Article Type] Meta-Analysis
Extensive Thrombosis in a Severe COVID-19 Patient Despite Prophylactic Low Molecular Weight HeparinInternal Medicine Published on 2020-10-252022-10-31 Journal: Cureus [Category] COVID-19, [키워드] anticoagulation China COVID COVID-19 D-dimer Extensive healthy heparin independent Mortality Patient Prophylactic prophylactic dose rv thrombus severe coronavirus disease severe COVID-19 disease shown thrombosis weight [DOI] 10.7759/cureus.11152 PMC 바로가기 [Article Type] Internal Medicine
Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2Review Published on 2020-10-242023-06-15 Journal: Anatolian journal of cardiology [Category] MERS, SARS, [키워드] antithrombotic therapy clinical outcomes COVID-19 D-dimer Disseminated intravascular coagulation heparin Inflammation Low molecular weight heparins Oral anticoagulants SARS-CoV-2 thrombosis [DOI] 10.14744/AnatolJCardiol.2020.56727 PMC 바로가기 [Article Type] Review
A case of urgent colonoscopic hemostasis of a cecal hemorrhagic ulceration in a patient receiving heparin for COVID ‐19 coagulopathyCase Report Published on 2020-10-232022-10-29 Journal: JGH Open: An Open Access Journal of Gastroenterology and Hepatology [Category] COVID-19, [키워드] assistant bleeding bloody Case report cause Coagulopathy Colonoscopy Contamination COVID COVID‐19 COVID‐19 cytomegalovirus diagnosed equipment hemorrhage Hemorrhagic Hemostasis heparin initiated management measure operator Patient performed Personal protective equipment Pneumonia positive Prevent receiving RNA Stool the patient was performed [DOI] 10.1002/jgh3.12435 PMC 바로가기 [Article Type] Case Report
Why Does COVID-19 Affect Patients with Spinal Cord Injury Milder? A Case-Control Study: Results from Two Observational CohortsArticle Published on 2020-10-212022-10-30 Journal: Journal of Personalized Medicine [Category] COVID-19, [키워드] Admission Affect Analysis Clinical characteristics Coagulation Complication CORD coronavirus correlation COVID-19 COVID-19 infection COVID-19 pandemic dose General population heparin identify IMPROVE Infection intensive care unit management molecular Patient Perspective platelet activation Protein Quantitative Result spinal Spinal cord injury Symptom therapeutic option These data Variation viral respiratory infection [DOI] 10.3390/jpm10040182 PMC 바로가기 [Article Type] Article
Decoding the silent walk of COVID-19: Halting its spread using old bulletsReview Published on 2020-10-192023-06-15 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] MERS, SARS, [키워드] Chloroquine heparin noscapine Remedesivir Severe acute respiratory syndrome (SARS-CoV2) Vitamin C [DOI] 10.1016/j.biopha.2020.110891 PMC 바로가기 [Article Type] Review
Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMOOriginal Article Published on 2020-10-192022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] activated acute phase reactants Analysis anti-Xa aPTT association C-reactive protein Concentration coronavirus disease correlated correlation COVID-19 COVID-19 patient CRRT dosage ECMO explained extracorporeal membrane oxygenation ferritin fibrinogen FVIII heparin Heparin resistance heparin therapeutic range Linear regression mandatory material monitoring objective optical patients Prevent renal replacement therapy Result therapeutic Thrombocytes Treatment variable were measured were used [DOI] 10.1055/s-0040-1719083 PMC 바로가기 [Article Type] Original Article
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study중증 COVID-19 환자에서 사이토카인 폭풍을 완화하기 위한 저분자량 헤파린의 가능성: 후향적 코호트 연구Article Published on 2020-10-152022-09-25 Journal: Clinical and translational science [Category] MERS, SARS, 진단, 치료제, [키워드] “cytokine storm” attenuate change changes in clinical study complementary control group coronavirus disease COVID‐19 D‐dimer Disease progression drug electronic medical record evaluate the effect fibrinogen degradation product global pandemic heparin Hospitalized IL‐6 Laboratory LMWH low molecular weight lymphocyte Patient performed Potential reduced Retrospective analysis SARS‐CoV‐2 Science significantly storm subsequent Support technology therapeutic drug treated Treatment Union Hospital university virus weight World Health Organization [DOI] 10.1111/cts.12880 PMC 바로가기 [Article Type] Article
Increased Plasma Heparanase Activity in COVID-19 PatientsImmunology Published on 2020-10-062022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] activity applied clinically contribute COVID-19 COVID-19 patient COVID-19 patients creatinine disease severity elevated endothelial Endothelial dysfunction enzyme glycocalyx damage healthy control Heparanase heparin Hypothesis Increased Inflammation inhibited inhibitor intensive care lactate dehydrogenase LMWH LMWH (low molecular weight heparin) low molecular weight molecular weight non-ICU patient pathogenesis of COVID-19 plasma Prophylactic reduced report significantly Therapeutic treatment vascular leakage were measured [DOI] 10.3389/fimmu.2020.575047 PMC 바로가기 [Article Type] Immunology
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort studyResearch paper Published on 2020-10-052022-10-31 Journal: EClinicalMedicine [Category] COVID-19, [키워드] Adjusted analysis Admission analyzed caused Cohort cohort study collected coronavirus Coronavirus disease 2019 COVID-19 death rate Effect Endothelial cell enoxaparin evaluated Evidence finding foundation heparin hospital Hospital stay Hospitalization hypercoagulability in-hospital mortality Infection intensive care intensive care unit Invasion Logistic regression low molecular weight heparin Mortality multivariate nine overlap weight Patient patients hospitalized patients treated Poisson regression polymerase chain positive Proinflammatory cytokine randomized clinical trial Rate Ratio real time reduce reduced risk respiratory reverse transcription risk RT-PCR SARS-CoV-2 SARS-COV-2 infection Secondary outcomes Support Thromboprophylaxis Treatment was used [DOI] 10.1016/j.eclinm.2020.100562 PMC 바로가기 [Article Type] Research paper